In the closing of the recent trading day, Moderna (MRNA) stood at $27.54, denoting a +2.53% move from the preceding…
In the most recent trading session, Moderna (MRNA) closed at $25.90, indicating a +1.97% shift from the previous trading day.…
…
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects…
Modernas shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the…
US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults…
…
An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…
An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…
Nächster Paukenschlag in den USA: Gesundheitsminister Robert F. Kennedy Jr. hat alle Mitglieder eines Gremiums (ACIP) von Impfexperten der US-…
Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul…
…
Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says…
FDA grants limited approval to Moderna’s new mRNA COVID vaccine…
…
These are the stocks posting the largest moves in the premarket.…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares edged higher after the US Food and Drug Administration (FDA) approved its newest COVID-19 vaccine…
The U.S. approved a new Covid-19 vaccine made by Moderna but with limits on who can use it — not…
…
Moderna at Bernstein Conference: Strategic Diversification Plans…
The Trump administration canceled $766 million awarded to Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including…
The government scraps funding deal for MRNAs bird flu shot, despite encouraging safety and efficacy data from early clinical studies…
Bad Marienberg (www.aktiencheck.de) - Die jüngste Entscheidung der US-Regierung, einen Vertrag über insgesamt 766 Millionen USD mit Moderna Inc. (ISIN:…
The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for…
US cancels more $700 million funding for Moderna bird flu vaccine…
Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.…
Moderna files application for updated COVID vaccine…
Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and…
Modernas voluntary withdrawal of the filing stems from the FDAs request for vaccine efficacy data from a phase III study…
Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and…
These are some of the stocks posting the largest moves in midday trading.…
…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares jumped more than 6.5% on Tuesday after the US Food and Drug Administration unveiled a…
Modern commerce still runs on the most volatile of fuels: human motivation.…
Moderna plans to launch 10 new marketed products over the next three years, aiming to diversify a revenue base, which…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) could face a longer-term threat from a newly announced US government initiative to develop universal vaccines…
The headline numbers for Moderna (MRNA) give insight into how the company performed in the quarter ended March 2025, but…
…
MRNA reports mixed Q1 results. The company reiterates 2025 sales guidance but announces a cost-cutting initiative to reduce expenses significantly…
Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the companys cost-cutting efforts following…
London (www.aktiencheck.de) - Moderna-Aktienanalyse von HSBC:
Aktuelle Bewertung
HSBC hat das Kursziel für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Sanford C. Bernstein & Co:
1. Hintergrund
Bernstein hat das Kursziel für die Aktie von Moderna…
…
In many ways, the pandemic is becoming a faded memory. With that, a major pandemic star -- biotech Moderna (NASDAQ:…
What should investors do during a stock-market correction? One great strategy is to go shopping. A bull market will eventually…
The latest trading day saw Moderna (MRNA) settling at $27.19, representing a -0.75% change from its previous close.…
Moderna (MRNA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and…
Moderna erreicht neues Jahres-Tief bei 21,67 Euro. Analysten halten sich mit Empfehlungen zurück, während wichtige Termine bevorstehen. Die Moderna-Aktie zeigt…
Moderna (MRNA) reachead $24.73 at the closing of the latest trading day, reflecting a -1.85% change compared to its last…